Current Environment: Production

Wai Wong | Medical Services

Programs & Services

Languages

  • English

Wai Wong | Education

Undergraduate School

University of Michigan

Ann Arbor, MI

Medical School

Stony Brook University School of Medicine

Stony Brook, NY

Internship

New York University

New York, NY

Residency

New York University

New York, NY

Fellowship

Boston Children's Hospital

Boston, MA

Wai Wong | Certifications

  • American Board of Pediatrics (General)
  • American Board of Pediatrics (Pulmonology)

Wai Wong | Publications

  1. Primary graft dysfunction grade 3 following pediatric lung transplantation is associated with chronic lung allograft dysfunction. J Heart Lung Transplant. 2023 05; 42(5):669-678. View Primary graft dysfunction grade 3 following pediatric lung transplantation is associated with chronic lung allograft dysfunction. Abstract

  2. Gene expression profiling distinguishes prefibrotic from overtly fibrotic myeloproliferative neoplasms and identifies disease subsets with distinct inflammatory signatures. PLoS One. 2019; 14(5):e0216810. View Gene expression profiling distinguishes prefibrotic from overtly fibrotic myeloproliferative neoplasms and identifies disease subsets with distinct inflammatory signatures. Abstract

  3. Myeloproliferative neoplasms: Diagnostic workup of the cythemic patient. Int J Lab Hematol. 2019 May; 41 Suppl 1:142-150. View Myeloproliferative neoplasms: Diagnostic workup of the cythemic patient. Abstract

  4. Clinicopathological and molecular features of SF3B1-mutated myeloproliferative neoplasms. Hum Pathol. 2019 04; 86:1-11. View Clinicopathological and molecular features of SF3B1-mutated myeloproliferative neoplasms. Abstract

  5. Concomitant classic Hodgkin lymphoma and schistosomiasis. Am J Hematol. 2019 07; 94(7):840-841. View Concomitant classic Hodgkin lymphoma and schistosomiasis. Abstract

  6. Alternate PAX3-FOXO1 oncogenic fusion in biphenotypic sinonasal sarcoma. Genes Chromosomes Cancer. 2016 Jan; 55(1):25-9. View Alternate PAX3-FOXO1 oncogenic fusion in biphenotypic sinonasal sarcoma. Abstract

  7. Hypoxia-inducible factors regulate filaggrin expression and epidermal barrier function. J Invest Dermatol. 2015 Feb; 135(2):454-461. View Hypoxia-inducible factors regulate filaggrin expression and epidermal barrier function. Abstract

  8. MYC degradation under low O2 tension promotes survival by evading hypoxia-induced cell death. Mol Cell Biol. 2013 Sep; 33(17):3494-504. View MYC degradation under low O2 tension promotes survival by evading hypoxia-induced cell death. Abstract

  9. Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell. 2010 Oct 22; 40(2):294-309. View Hypoxia-inducible factors and the response to hypoxic stress. Abstract

  10. The role of MXI1 in VHL deficient tumorigenesis. Cancer Biol Ther. 2008 Oct; 7(10):1628-9. View The role of MXI1 in VHL deficient tumorigenesis. Abstract

BESbswy